Article
Two tagging single-nucleotide polymorphisms to capture HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 haplotype associated with asparaginase hypersensitivity.
British journal of clinical pharmacology - 1 Jun 2021
Kutszegi Nóra, Gézsi András, F Semsei Ágnes, Müller Judit, Simon Réka, Kovács Erika Rozália, Hegedüs Katalin, Kovács Gábor T, Szalai Csaba, Erdélyi Dániel J
Abstract excerpt
AIMS: Asparaginase (ASP) hypersensitivity is a well-known challenge in the treatment of lymphoblastic malignancies. In terms of cost considerations, the cheap native Escherichia coli ASP, the most immunogenic form of this medication, is used in the first line in middle-income countries. Previously, the role of the HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 haplotype had been established to associate with E. coli ASP...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
